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Abstract
Background:  Pain referral patterns of asymptomatic costotransverse joints have not been
established. The objective of this study was to determine the pain referral patterns of asymptomatic
costotransverse joints via provocative intra-articular injection.
Methods: Eight asymptomatic male volunteers received a combined total of 21 intra-articular
costotransverse joint injections. Fluoroscopic imaging was used to identify and isolate each
costotransverse joint and guide placement of a 25 gauge, 2.5 inch spinal needle into the
costotransverse joint. Following contrast medium injection, the quality, intensity, and distribution
of the resultant pain produced were recorded.
Results: Of the 21 costotransverse joint injections, 16 (76%) were classified as being intra-articular
via arthrograms taken at the time of injection, and 14 of these injections produced a pain sensation
distinctly different from that of needle placement. Average pain produced was 3.3/10 on a 0–10
verbal pain scale. Pain was described generally as a deep, dull ache, and pressure sensation. Pain
patterns were located superficial to the injected joint, with only the right T2 injections showing
referred pain 2 segments cranially and caudally. No chest wall, upper extremity or pseudovisceral
pains were reported.
Conclusion: This study provides preliminary data of the pain referral patterns of costotransverse
joints. Further research is needed to compare these findings with those elicited from symptomatic
subjects.
Background
The thoracic spine has been described as the enigma
within the vertebral column, with the diagnosis of pain
originating from this region being historically problem-
atic for the practitioner [1-5]. The neural complexity of the
thoracic spine, along with referred visceral pain leads to
poor pain source localization [6-8]. Research of thoracic
spine pain referral patterns has been relatively sparse
when compared to the cervical and lumbar spine
regions[2,9-13], despite reports of equally disabling pain
from this region[2,13-16].
The costotransverse and costovertebral joints are often
suspected as sources of referred thoracic pain only after
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costly and often unnecessary negative visceral work-ups
have been performed[2,17-20]. One example is T4 syn-
drome, a symptom complex originating in the upper tho-
racic spine and includes glove-like paresthesias of one or
both upper limbs, referred pain into the neck and scapular
regions, and a dull, aching generalized headache [21-23].
Successful treatment has been reported in case studies
using manipulation and exercise intervention [21-23],
despite the unknown cause of T4 syndrome. Both the tho-
racic intervertebral disks and thoracic zygapophyseal
joints are thought to be primary pain generators in T4 syn-
drome based on their pain patterns, suggesting that dys-
function of the costotransverse joint may be implicated as
well[13].
Costotransverse joints cannot be assumed to be a source
of pain solely on the basis of pain mapping findings from
other joints in the vertebral column[13]. Therefore, pain
referral mapping in asymptomatic volunteers can provide
information on the potential of the costotransverse joints
to be a source of pain, and potentially to recreate clinically
observed pain syndromes. This has been undertaken in
thoracic zygapophyseal joints, where pain patterns have
been documented in asymptomatic volunteers[13], as
well as in subjects with thoracic pain[14]. Clinical pain
patterns from the costotransverse joints have been
hypothesized[3,20,24]. However, pain referral patterns
for the costotransverse joints have yet to be definitively
investigated. The suspected pain patterns from the cos-
totransverse joints are likely similar to the thoracic zygap-
ophyseal and costovertebral joints. Innervation of the
costotransverse joints is from the lateral branch of the tho-
racic dorsal rami, whereas the thoracic zygapophyseal
joints are innervated by the medial branches of the tho-
racic dorsal rami[8]. Costovertebral joints have been
shown to receive sympathetic innervations from the
neighboring sympathetic segment and the segment cra-
nial to it[25]. Therefore, the purpose of this study was to
identify and record the pain referral pattern of the asymp-
tomatic costotransverse joint, and to stimulate further
investigation of the costotransverse joints.
Methods
Subjects
Eight asymptomatic male subjects (36 years ± 7.3 years)
without history of thoracic pain participated in the study.
This study was approved by the Investigational Review
Board at Wilford Hall Medical Center, Lackland Air Force
Base, Texas. Informed consent was obtained from all sub-
jects prior to participation. Pretest imaging studies of the
costotransverse joints were not performed.
Costotransverse Joint Selection
Subjects were allocated to receive consecutive, same-day
right-sided T2, T4 and T6 costotransverse joint injections,
or consecutive, same-day left-sided T3, T5 and T7 cos-
totransverse joint injections. Subjects were not blinded to
the level of injection, but were blinded to pain pattern
responses in prior subjects.
Fluoroscopy Guidelines
No duration of imaging was stated in the original descrip-
tion of technique reference[26]. Therefore, to minimize
exposure to radiation, the total exposure to fluoroscopy
was limited to 6 minutes or less per subject, as determined
by the Wilford Hall Medical Center Radiation Safety
Officer. This was calculated to provide the equivalent
amount of radiation as 3.3 years of exposure to natural
background radiation (7800 mR).
Injection Procedures
The technique for injection has been previously
described[26]. No sedation was utilized as was reported in
the initial technique description[26]. Injections were per-
formed with the patient in the prone position and not the
prone oblique position as previously documented due to
the inherent mobility of the C-arm fluoroscopy used in
this study.
Once the subject was positioned prone, the skin overlying
the target joint was prepped with betadine. Using inter-
mittent video fluoroscopy, the target joint space was iso-
lated and the point of needle insertion marked.
Xylocaine® (AstraZeneca LP, Wilmington, DE) (1.0%, 2
cc's) was then injected directly under the skin for topical
anesthesia. A 25 gauge, 2.5 inch spinal needle was
inserted into the underlying costotransverse joint guided
by intermittent fluoroscopy toward the identified joint
space. Imaging was performed in multiple angles (antero-
posterior, as well as 30–45° oblique with a slight cephalic
tilt) to guide needle advancement, and for verification of
needle placement within the identified joint space as pre-
viously described by Dreyfuss[13]. The joint was then
injected with ≤ 0.5 cc Omnipaque™ 240 (iohexol) Injec-
tion (contrast medium) (GE Healthcare Biosciences/
Amersham Health, Piscataway, NJ) under constant imag-
ing to distend the joint. Injection was continued until
pain or pressurization of the capsule occurred allowing no
additional contrast to be safely injected, or extracapsular
spread of the contrast medium was noted by fluoros-
copy[13]. An arthrogram was taken to document needle
placement, joint selection, and for later data analysis.
Outcome Measurements
Image Classification
All costotransverse joint arthrograms were analyzed to
determine the extent of contrast within the joint, and thus
to delineate between successful and unsuccessful joint
injections. All images were analyzed by one investigator
(HG). The following rating scale was utilized:BMC Musculoskeletal Disorders 2008, 9:140 http://www.biomedcentral.com/1471-2474/9/140
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Good
An arthrogram which clearly outlines the extent of the
joint and capsule.
Equivocal
An arthrogram which demonstrates some contrast within
the joint, but does not clearly outline the extent of the
joint or extravasates outside the joint.
Poor
Unable to determine if contrast is within the joint.
Successful joint injections were those rated as either good
or equivocal.
Pain and Symptom Assessment
During each injection subjects were asked to distinguish
between the sensations of the needle insertion/advance-
ment and capsule distention. The numeric pain rating
scale (0 = no pain; 10 = worst imaginable pain) was uti-
lized to report the level of pain induced with capsular dis-
tension [27-29]. Subjects were also instructed to describe
the pain/sensation induced and any referred pain, utiliz-
ing a list of pain descriptors, as well as self-selected
descriptors.
Composite Pain Map Construction
The needle insertion point was circled and labeled with a
skin marker, and the distribution of pain produced from
the joint injection was also marked and labeled on the
subject's skin by the injectionist via palpation and verbal
interaction with the subject. Once the pain markings were
complete, a digital photograph was taken of the pain dis-
tributions to allow accurate representation on a compos-
ite pain drawing. A separate investigator mapped the pain
patterns on a body diagram. A composite pain map was
then created from the individual joint maps.
Results
No complications occurred in any subject from participa-
tion in this study. The mean radiation exposure time was
4.85 ± 1.03 minutes. Out of 24 potential costotransverse
joint injections, a total of 21 injections were completed.
The breakdown of the number of injections by joint and
their classification, along with reasons for unperformed
injections, are depicted in Table 1. Six arthrograms from
the 21 completed costotransverse joint injections (29%)
were classified as good, and 10 (47%) were classified as
equivocal. Extracapsular spread of the injected medium
was one reason to terminate further injection into the
joint. As there were no differences in the pain pattern
reported for those joints rated as good and equivocal, and
there was evidence of intracapsular injection prior to the
extracapsular spread, the good and equivocal groups were
therefore combined into a "successful" injections category
for the remainder of the analysis. The remaining 5 (24%)
joint arthrograms were classified as poor, giving our accu-
racy of needle placement into the costotransverse joint
utilizing fluoroscopy as 76%. Examples of each classifica-
tion are presented in figures 1, 2, 3.
Of the 16 successful costotransverse joint injections, 14
(88%) of these injections produced a sensation during
capsular distension distinctly different from that of needle
placement. One left T3 injection, and one right T4 injec-
tion did not produce a pain sensation distinctly different
from needle placement. The average pain from capsular
distension for the 14 symptom producing injections was
3.3 ( ± 1.8) on the 0–10 numeric pain rating scale.
The individual pain patterns from those 14 costotrans-
verse joint injections which produced a distinct capsular
distension sensation were combined to create the cos-
totransverse joint composite pain map (Figure 4). In gen-
eral reports of pain sensations were ipsilateral, and
remained local to the target joint. Only pain elicited from
the right T2 injections appeared to refer approximately 2
vertebral segments superior and inferior from the target
joint. One subject did note tightness across the abdomen
at the level of the xyphoid process with a right T6 injec-
tion. Provoked symptoms were described generally as a
deep, dull ache and pressure sensation, with one subject
describing a left T5 joint provoked pain as a sharp, burn-
ing pressure, and another left T5 described as a sharp pres-
sure. The average volume of contrast medium injected was
0.4 cc (SD ± 0.1 cc).
Table 1: Frequency of costotransverse joint injections and ratings.
Right T2 Right T4 Right T6 Left T3 Left T5 Left T7
# injections attempted 3 4 2 4 4 4
# injections not performed 1† 2‡
# Good injections 2 0 0 1 1 2
# Equivocal injections 1 3 2 3 1 0
# Poor injections 1 2 2
† Difficulty visualizing joint space due to scoliosis.
‡ One due to imaging time constraints; one due to inability to visualize costotransverse joint on fluoroscopy.BMC Musculoskeletal Disorders 2008, 9:140 http://www.biomedcentral.com/1471-2474/9/140
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Discussion
This is the first study to attempt to document the pain
referral patterns of asymptomatic costotransverse joints.
We have initiated this process as outlined by Dwyer and
colleagues[11]: first, a joint should produce pain when
stimulated in normal volunteers; second, in patients with
similar forms of pain, the pain should be relieved with
anesthetization.
Due to the invasive nature and risk of this type of investi-
gation, we limited this study to a small number of asymp-
tomatic subjects to determine preliminary pain
patterns[11,13]. From the small number of joints stimu-
lated, it appears that there is a reproducible pattern and
sensation of pain from asymptomatic costotransverse
joints. This pattern was local to the target joint, and con-
sistent with Hilton's Law, which states that the innerva-
tion of a joint is the same innervation as the muscles
which move the joint and the skin overlying the joint.
The provoked pain patterns significantly overlap the pain
patterns described in prior studies stimulating other spi-
nal and soft tissue structures[9,13,14]. Therefore, pain
patterns are unreliable in diagnosis. Further investigative
work to identify symptomatic costotransverse joints will
need to be performed to both stimulate and then anesthe-
tize these joints in patients presenting with thoracic
pain[10,30]. This procedure will not only aid in valida-
tion of our findings in symptomatic patients, but will also
lay the foundation for therapeutic costotransverse joint
injections. With a 34–48% prevalence of thoracic zygapo-
physeal joint pain, and a 42–58% false-positive rate [31-
33], it is anticipated that a large number of patients would
be required to ascertain true costotransverse joint data.
Two of the successful costotransverse injections (12%)
did not provoke a sensation upon capsular distension that
was distinguishable from needle insertion/placement.
Dreyfuss[13] reported non-painful response to capsular
distension in 27% of thoracic zygapophyseal joint injec-
tions in asymptomatic subjects. This non-painful
response may have been due to an insufficient amount of
contrast medium being injected to cause capsular disten-
tion[11,13], or due to the use of a non-irritating injection
agent. Although Lau[26] reported injecting a total of 1.7
cc of fluid into the costotransverse joint when describing
the costotransverse joint injection technique, no studies
have reported on the available volume for this joint. Since
the costotransverse joints are anatomically smaller than
the zygapophyseal joints, we utilized the amount of fluid
injected into the zygapophyseal joints[13] as a baseline
for estimating the volume limit for the costotransverse
joints. Dreyfess[13] injected between 0.4 to 0.6 ml. There-
fore, we elected to limit the volume injected into the cos-
totransverse joint to no greater than 0.5 cc as a precaution
to prevent rupturing the joint capsule from overpressuri-
zation. Perhaps this amount of contrast was insufficient to
cause adequate capsular distension in two of our cos-
Image of Equivocal injection, Left T3 Figure 2
Image of equivocal injection, left T3.
Image of good injection, right T2 Figure 1
Image of good injection, right T2.BMC Musculoskeletal Disorders 2008, 9:140 http://www.biomedcentral.com/1471-2474/9/140
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totransverse joints to provoke a symptomatic response.
However, only 12% of our joints were asymptomatic as
compared to 27% of zygapophyseal joints, perhaps sug-
gesting our volume selection was appropriate due to the
smaller size of the costotransverse joint compared to the
zygapophyseal joint.
We used a non-irritating contrast agent in an attempt to
provoke symptoms from capsular distension, similar to
the state of joint effusion rather than chemical irritation.
However, inflammatory cyctokines released from joint tis-
sue irritated from needle insertion[34], stimulation of
joint capsule nerve endings during needle penetration,
and irritation of the joint synovium may have been other
sources of elicited symptoms. Our interest was the symp-
tom produced upon the injection of contrast medium
into the joint, and patients were asked to distinguish this
sensation from that of needle placement. Approximately
1–2 minutes lapsed between the needle placement and
the injection of contrast medium, as the needle placement
was verified by fluoroscopy from two imaging angles.
Non-contrast agents have been used extensively in prior
pain pattern studies[11,13,35], and have been success-
fully used to stimulate symptomatic thoracic zygapophy-
seal joints[14] in an effort to reproduce thoracic pain. Had
hypertonic saline been utilized, a potentially more nox-
ious stimulus, the pain referral patterns observed may
have been broader in range, more intense, or other clini-
cally reported symptoms may have been pro-
voked[11,35].
Five of our arthrograms were rated as poor, and thus not
included in our analysis. Although we attempted to verify
needle placement in each joint before the injection of
contrast medium, the intricate anatomy of the costotrans-
verse joint may have been the biggest limitation of our
study, possibly limiting the ability to fully place the nee-
dle within the joint space. The costotransverse joint is the
synovial articulation between the rib tubercle of typical
ribs and the vertebral transverse process[36]. The narrow
costotransverse joint space is surrounded by a thin articu-
lar capsule and strong costotransverse ligaments which
tightly bind the joint and limit mobility to slight gliding
motions. It is bounded laterally by the rib tubercle and
posteriorly by the transverse process, which greatly limits
its accessibility. This study is additionally limited by the
intricate biomechanical relationship between the cos-
totransverse and costovertebral joints[37], adding further
complexity to the diagnosis of thoracic pain. Finally, it is
well documented that pain referral patterns of the spine
are insufficient in determining the exact source of pain,
because of their overlap[7]. More specific diagnosis and
treatment approaches are needed, such as the use of
medial branch blocks in the evaluation of potential tho-
racic zygapophyseal joint mediated pain[30].
Further studies exploring the pain patterns of the cos-
totransverse joint are needed to validate these findings in
symptomatic patients. One possibility would be to stimu-
late and then anesthetize the costotransverse joints in
patients presenting with this pain pattern to determine
response, as has been performed in thoracic zygapophy-
seal joints[14]. Validation of provoked pain patterns has
been performed in the cervical spine, demonstrating that
the evoked patterns in normal volunteers can be clinically
Composite diagram of costotransverse joint pain patterns Figure 4
Composite diagram of costotransverse joint pain 
patterns.
Image of Poor injection, Left T5 Figure 3
Image of poor injection, left T5.BMC Musculoskeletal Disorders 2008, 9:140 http://www.biomedcentral.com/1471-2474/9/140
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accurate[10]. In developing further studies, alternative
imaging techniques for these injections should be consid-
ered in an attempt to minimize exposure to radiation.
Ultrasound-guided facet injections have initially been
studied for cervical[38] and lumbar[39] facets.
Conclusion
This study provides preliminary data on the pain referral
patterns of the costotransverse joints. From the small
number of joints stimulated, it appears that there is a
reproducible pattern and sensation of pain from asympto-
matic costotransverse joints.
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